Comprehensive Diagnostic Evaluations
Nationally Recognized
Independent
Unaffiliated
The Center for Diagnostic Evaluations
Our Mission
At The Center for Diagnostic Evaluations, our mission is to provide thorough, medically sound and respectful evlauations for medical professionals who are in need of a Multisciplianry Comprehensive Diagnostic Evaluation. We strive to make our clients feel comfortable and cared for during every encounter.
Evaluation Goals
NATIONALLY RECOGNIZED
APPROVED BY U.S. LICENSING BOARDS
INDEPENDENT and UNAFFILIATED
The goals of our Comprehensive Diagnostic Evaluation (CDE) process are threefold:
- Determine whether or not the client meets current DSM criteria for a substance use disorder (SUD), or any other psychiatric condition that may impact their ability to practice medicine with reasonable skill and safety.
- In the event the client does meet current DSM criteria for an SUD and/or another psychiatric, psychological, or cognitive condition, make appropriate treatment recommendations.
- Determine whether or not the client is currently safe to practice medicine.
Our CDE Team
Gregory Skipper MD
Distinguished Fellow, American Society of Addiction Medicine, Board Certified Internal Medicine, Addiction Medicine
Dr. Skipper is a Fellow of the American Society of Addiction Medicine and a certified medical review officer. He previously served as medical director for the Alabama Physician Health Program and was on the council that created and oversaw the Oregon Health Professionals Program. Dr. Skipper was the primary innovator of ethyl glucuronide (EtG) testing and is an expert in alcohol biomarkers and drug testing. He was a principal investigator of the National Physician Health Program Blueprint Study, funded by a Robert Wood Johnson Foundation grant, and is the author of many articles regarding drug testing, physician health, and contingency monitoring. Dr. Skipper was formerly medical director of Springbrook Hazelden, and he was a chief advisor to the development of the professional’s program at Promises, Betty Ford Center and Bradford Health Services.
Matthew Goldenberg, DO
General and Addiction Psychiatry
Matthew Goldenberg D.O. is double board-certified in psychiatry and addiction psychiatry and is a certified Medical Review Officer (MRO). He is an expert in the evaluation and treatment of mental health disorders and has provided addiction psychiatry consultations to some of the nation’s top addiction treatment programs. In addition to his clinical work, Dr. Goldenberg is an active author, researcher and invited speaker at local and national conferences. He volunteers his time as a clinical instructor in the Department of Psychiatry at UCLA and is an assistant professor of psychiatry at Cedars Sinai Medical Center. Dr. Goldenberg completed an addiction psychiatry fellowship through UCLA, in Los Angeles, California, and psychiatry residency at Banner University Medical Center of the University of Arizona, in Phoenix, Arizona. He completed medical school at Midwestern University, Arizona College of Osteopathic Medicine, and is a native of Los Angeles.
Laura Dorin, PhD
Licensed Psychologist
Dr. Laura Dorin is an established licensed psychologist specializing in comprehensive, empirically based, fitness for duty evaluations in cases referred by licensing boards, regulatory agencies, businesses, and professional organizations. Dr. Dorin assesses employee or job applicant fitness for duty as well as professional misconduct in the workplace, including sexual workplace violations and/or substance issues. In her assessments, Dr. Dorin utilizes interview and test data in order to determine if the individual is able to perform the essential functions of their position in a manner that is safe for themselves, co-workers, clients, or the public.
John Pustaver, MDiv, MA
Program Director
John Pustaver, MDiv, MA, completed his undergraduate education at Arizona State University majoring in fine arts. Ordained to the priesthood in 1987, John served the Archdiocese of Los Angeles for ten years. Prior to electing to retire from the priesthood, John found his spiritual path within the 12-Step recovery community in 1992 while serving as spiritual director at the invitation of Patrick Carnes, PhD, at Del Amo Hospital's SDU unit (1992-1999). John then completed 60 hours of MFT coursework while working at the Betty Ford Center’s professionals program (2002-2014) He became the director of their Clinical Diagnostic Program after learning the science and art of conducting professional evaluations. John has been involved in professional assessments and treatment for 25 years and has found a unique way serving professionals in crisis. John’s responsibilities with the Center for Diagnostic Evaluations includes directing and overseeing our CDE process, the collection and review of collateral information, remaining in contact with referents and preparing the final summary report (Integrated Evaluation Summary) for the CDE Team.
Differential Diagnosis
Co-Occurring Substance Abuse and Mental Health Disorders
- Substance misuse does not occur in isolation for many individuals. It is common for substance use disorders (SUD) to coincide with other psychiatric disorders commonly known as a co-occurring disorder. Approximately 7.9 million U.S. adults were diagnosed with a co-occurring disorder in 2014, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). Despite its prevalence, the complexity of symptoms in a co-occurring disorder requires expertise and experience with differential diagnosis.
Cause and Effect
- Determining how a co-occurring disorder develops can also be elusive. In some cases, the mental health disorder is present first, and the individual turns to drugs and alcohol as a means of managing their symptoms. Often referred to as "self-medicating," this process seems to offer some relieft - at first. However, if "self-medicating" with substances increases it will likely become its own problem, causing "the solution" to meet DSM criteria for SUD, mild, moderate, or severe.
Co-Occurring Disorders in the Professional World
- Medical professionals (physicians, dentists, pharmacists, nurses and physician assistants) usually struggle for some time to keep their difficulties a secret for many reasons including the fear of damaging their reputations. These individuals may be more apt to turn to drugs and alcohol in an attempt to manage the condition on their own. Once the substance use becomes problematic as well, a vicious cycle can ensue as the professional tries to hide both disorders from their peers, patients and clients. The consequences can be severe as many professionals find their careers and personal relationships in jeopardy over time.
Mental Health Disorders Commonly Seen with Substance Misuse
Depression
- This disorder is more than feeling “sad” or “blue” on occasion. Clinical depression is marked by extended periods of hopelessness and sadness, coupled with physical symptoms like lack of energy, sleep disruptions and chronic pain. Severe cases can also lead to suicidal thoughts and ideations. Substance abuse is a common byproduct as people struggling with depression might turn to stimulants to increase energy or alcohol, opioids or benzodiazepines to unwind after a busy day.
Anxiety Disorders
- Anxiety is a common byproduct of life, but when it starts to take over a person’s daily function, it may meet DSM criteria for a anxiety-related disorder. Anxiety disorders may be generalized, or they may pertain to fear of a specific event or object, such as a phobia. Severe cases may lead to a person avoiding certain places, things or situations to prevent the anxious feelings from surfacing. Professionals struggling with anxiety may find this disorder significantly impairs their ability to perform their jobs.
Bipolar Disorder
- Bipolar disorder is characterized by extreme mood swings, that might happen over a period of hours, days or months. High fluctuations or manic phases lead to increased energy levels, and possible irritability. Low swings or depressive phases might include decreased energy, feelings of hopelessness and thoughts of suicide in extreme cases.
OCD
- Obsessive-compulsive disorder or OCD is a condition in which a person is plagued with recurrent thoughts or obsessions. To control the thoughts, the person will adopt repetitive behaviors like handwashing, money counting or rechecking things. The actions are not welcome or pleasant, but they can become nearly impossible to stop without professional treatment.
PTSD
- Post-traumatic stress disorder or PTSD occurs after a life-threatening, traumatic event like an attack, vehicle crash or natural disaster. It is also commonly seen in war veterans that have experienced combat. The condition can appear months or even years after the event and is characterized by horrifying nightmares and flashbacks.
ADHD
- Attention deficit disorder (ADD) and attention-deficit/hyperactivity disorder (ADHD) are conditions that commonly present during childhood. However, the symptoms can persist into adulthood, making it difficult for some adults to maintain a steady job or have meaningful personal relationships. The presence of this brain disorder can also lead to low self-esteem and a lower quality of life.
Dr. Skipper's Publications
Dr. Skipper’s Publications
- Pham JC, Pronovost PJ, Skipper GE. Prevalence of Drug Testing Among Family Medicine Residents and Students: Much Needed Data. Journal of Graduate Medical Education March 2015, 128-130
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507906/ - Gordon A, Jaffe A, McLellan AT, Richardson G, Skipper GE, Sucher M, Tirado CF, Urschel H. How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings from an expert round table Discussion. J Addict Med, 2017 Mar/Apr;11(2):145-153 2016 • Merlo LJ, Campbell MD, Skipper GE, Shea CL, DuPont RL. Outcomes for Physicians With Opioid Dependence Treated without Agonist Pharmacotherapy in Physician Health Programs. JSAT 64 (2016) 47-54
https://www.ncbi.nlm.nih.gov/pubmed/28157829 - Rose JS, Campbell MD, Yellowlees P, Skipper GE, DuPont DL. Family Medicine Physicians with Substance Use Disorder: A 5-Year Outcome Study. JAM 2016 6 pages 2015 • Yellowlees PM, Skipper GE, et al. Psychiatrists with Substance Use Disorders: Positive Treatment Outcomes From Physician Health Programs, Psychiatric Services in Advance, pgs. 1-4
https://ps.psychiatryonline.org/doi/abs/10.1176/appi.ps.201300472?code=ps-site - Skipper GE. The Impaired Professional Part III, Understanding Addicted Physicians, Counselor Magazine, October 2015, 17-18 2014 • Pham JC, Pronovost PJ, Skipper GE. California’s Proposition 46: A Wolf in Sheep’s Wool. Annals of IM, 16 December 2014, Vol 161(12), 913-914. https://issuu.com/hcibooks/docs/counselor_october_sneakpeek
- DuPont RL, Shea CL, Skipper GE, et al. The New Paradigm for Recovery: Making Recovery – and Not Relapse – the Expected Outcome of Addiction Treatment. A White Paper Report of the John P McGovern Symposium. March 2014.
http://www.williamwhitepapers.com/pr/IBH%20Creating%20a%20New%20Standard%20for%20Addiction%20Treatment%20Outcomes%202014.pdf - Dammann G, Dursteler-MacFarland KM, Strasser H, Skipper GE, Wiesbeck GA, Wurst FM. Cannabis Use Among a Sample of 16 to 18 Year-old Students in Switzerland. Psychiatria Danubina, 2014:Vol.26, No. 1, pp56-65.
http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol26_no1/dnb_vol26_no1_56.pdf - Skipper GE, Thon N, DuPont RL, Campbell MD, Weinmann W, Wurst FM. Cellular Photo Digital Breathalyzer for Monitoring Alcohol Use: A Pilot Study. Eur Addict Res 2014:20:137-142. Curriculum Vitae: Gregory E. Skipper, M.D. 7 of 21 pages • Rose JS, Campbell M, Skipper GE. Prognosis for Emergency Room Physicians with Substance Abuse Recovery: 5 Year Outcome Study. Western Journal of Emergency Medicine. Vol XV, No 1, Feb 2014. 2013
https://www.ncbi.nlm.nih.gov/pubmed/24335415 - Pham JC, Pronovost PJ, Skipper GE. Identification of Physician Impairment. JAMA. 2013;():1-2. doi:10.1001/jama.2013.4635. • Skipper GE. Substance Disorders: Best Practices in Drug and Alcohol Testing Across a Continuum of Care. Alere Toxicology. Monograph 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23629590 - Wurst FM, Rumpf HJ, Skipper GE, Allen JP, Kunz I, Beschoner P, Thon N. Estimating the prevalence of drinking problems among physicians. Gen Hosp Psychiatry. 2013 Jul 5. doi:pii: S0163-8343(13)00139-4. 10.1016/j.genhosppsych.2013.04.018. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/23835083 - Skipper GE, Thon N, Dupont RL, Baxter L, Wurst FM. Phosphatidylethanol: The Potential Role in Further Evaluating Low Positive Urinary Ethyl Glucuronide and Ethyl Sulfate Results. Alcohol Clin Exp Res. 2013 Sep;37(9):1582-6 doi: 10.1111/acer.12121. June 3
https://www.ncbi.nlm.nih.gov/pubmed/23731162 - Skipper GE. State Physician Health Programs Protect the Public – And Save Careers. Federation of State Physician Health Programs Newsletter. Feb 2013. Vol 18. Pgs. 4-5. 2012
http://www.fsphp.org/sites/default/files/pdfs/acfrogc0xziawry1re9ghkqebqwsy6upc9exddrgpg53k8xmy99yzsdzsw8n0yvptvq4autw25wds39kxvs80u8vxcdlauobj7a742mqraq7h504mtxkmn3r2v8xl-e.pdf - Skipper GE, Schenthal S. Special from Missouri Physicians Health Program. Sexual misconduct by professionals: a new paradigm of understanding. Mo Med. 2012 MayJun;109(3):184-6. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/22860280 - Dupont RL, Skipper GE. Six lessons from state physician health programs to promote long-term recovery. J Psychoactive Drugs. 2012 Jan-Mar;44(1):72-8.
https://www.ncbi.nlm.nih.gov/pubmed/22641968 - Skipper GE, Williams J. Failure to Acknowledge High Suicide Risk among Veterinarians. Journal of Veterinary Medical Education, Issue 1, 2012, p.-1.
https://www.ncbi.nlm.nih.gov/pubmed/22433743 - Skipper GE, DuPont R, Martin D. A New Challenge for Drug-Free Workplace Programs. Journal of Occupational Health and Safety. Occup Health Saf. 2012 Feb;81(2):32, 34. Curriculum Vitae: Gregory E. Skipper, M.D. 8 of 21 pages 2011
https://ohsonline.com/Articles/2012/02/01/A-New-Challenge-for-Drug-Free-Workplace-Programs.aspx - Skipper GE, DuPont RL. The Advantages of Long-Term Monitoring. Addiction Professional. July 2011.
www.addictionpro.com/article/advantages-long-term-monitoring - Wurst FM, Thon N, Yegles M, Halter C, Weinmann W, Laskowska B, Strasser J, Skipper G, Wiesbeck GA, Dursteler-Macfarland K. Optimizing heroin-assisted treatment (HAT): Assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. Drug Alcohol Depend. 2010 Dec 7. (Epub ahead of print)
https://www.ncbi.nlm.nih.gov/pubmed/21145180 - Skipper GE, DuPont RL. The Physician Health Program: A Replicable Model of Sustained Recovery Management. (Chapter 17 pgs. 281-299) In: J.F. Kelly and W.L. White (eds.), Addiction Recovery Management: Theory, Research and Practice, Current Clinical Psychiatry, DOI 10.1007/978-1-60327-960-4_15, Springer Science+Business Media, LLC 2011
https://link.springer.com/chapter/10.1007/978-1-60327-960-4_15 - Skipper GE, DuPont RL. US Physician Health Programs: A Model of Successful Treatment of Addictions. Counselor: The Magazine for Addiction Professionals. Dec 2010. Vol 11(6) 22-30.
- Skipper GE. Medical Malpractice: Anatomy of a Lawsuit and Malpractice Stress Syndrome. Newsletter of the Missouri Physician Health Program. March 2010. Pgs. 2-8 2009
- Skipper GE. Confrontational approach has no role in addressing physician addiction. Mayo Clin Proc. 2009 Nov;84(11):1042-3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770919/ - Skipper GE. In Response to letter to the Editor. Anesthesia and Analgesia. Volume X. Number X. 2010, pg. 1
https://journals.lww.com/anesthesia-analgesia/fulltext/2015/05000/Anesthesiologists_and_Substance_Use_Disorders___An.41.aspx - Skipper GE. The value of physician health programs. Alabama Board of Medical Examiners Newsletter and Report. October – December 2009, Volume 24, Number 4, pgs. 1-4
http://www.albme.org/Documents/Newsletters/2009V24No4.pdf - Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with Substance Use Disorders: A 5- Year Outcome Study from 16 State Physician Health Programs. Anesth & Analg 109(3), Sept 2009, 891-896.
https://www.ncbi.nlm.nih.gov/pubmed/19690263 - Skipper GE, DuPont RL. Anesthesiologists Returning to Work after Substance Abuse Treatment. Anesthesiology, V110, No 6, June 2009 1426-28.
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/anesthesiologists_returning_to_work.anesthesiology.lte.skipper.only.pdf - DuPont RL, McLellan AT, Carr G, Gendel M, Skipper GE. How are addicted physicians treated? A national survey of physician health programs. JSAT 37 (2009) 1-7.
https://www.ncbi.nlm.nih.gov/pubmed/19482236 - Skipper GE, DuPont RL. What about Physician Health Programs. The New Republic. January 18, 2009 Curriculum Vitae: Gregory E. Skipper, M.D. 9 of 21 pages
- Skipper GE, Liepman M, Wurst FM, Weinmann W. Breathing Vapor of Ethanol-Based Hand Sanitizing Gel Vapor Causes Positive Alcohol Marker, Ethylglucuronide (EtG), and Positive Breathalyzer. (Accepted for publication by Journal of Addiction Medicine 11/25/2008)
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/ethgelpaperjam.pdf - Skipper GE, Schenthal SJ. Professional Sexual Misconduct: A new paradigm of understanding. Alabama Board of Medical Examiners Newsletter and Report, 23(3), July-Sept 2008, 1-6.
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/psm.albme.pdf - Physicians and Medical Workers, Substance Abuse Among. Encyclopedia of Drugs, Alcohol & Addictive Behavior, 3rd ed., Macmillan Reference USA, 2008, Vol 3, pages 242-251
- McLellan AT, Skipper GE, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ. 2008 Nov 4;a2038, doi:10.1136.a2038.
http://www.bmj.com/content/337/bmj.a2038 - White, W.L., DuPont, R.L., Skipper, G.E. (2008). Physician health programs: What counselors can learn from these remarkable programs. Counselor Magazine, June 27, 2007, 44-51
http://www.williamwhitepapers.com/pr/2007PhysicianHealthPrograms.pdf - Skipper GE, DuPont RL, White WL. Testing for Recent Alcohol Use. Perspectives – the Journal of the American Probation and Parole Association. 2008(32)3, 38-45
http://www.williamwhitepapers.com/pr/2008RecentAlcoholTesting.pdf - DuPont RL, Skipper GE, White WL. Testing for Recent Alcohol Use. Student Assistance Journal. Spring 2008 12-18
http://www.williamwhitepapers.com/pr/2008RecentAlcoholTesting.pdf - DuPont RL, Skipper GE, White WL. Testing for Alcohol Use. Counselor Magazine. April 2008(9) 44-51. • DuPont, R.L., Skipper, G.E. & White, W. L. (2007). Testing for recent alcohol use. Employee Assistance Digest, Winter2007,28(1), 15-21 2006
https://www.researchgate.net/publication/265480652_Testing_For_Recent_Alcohol_Use - Skipper GE, Schenthal S. Professional Sexual Misconduct – A Primer. Published on the Web, www. Professionalboundaries.com 2005
http://www.themphp.org/Archive/Articles/tabid/98/ArticleID/214/Professional-Sexual-Misconduct-A-new-paradigm-of-understanding.aspx - Skipper GE, Brase DA. Tramadol Abuse and Dependence among Physicians. JAMA. 2005; 293:1977-1978 2004
https://www.ncbi.nlm.nih.gov/pubmed/15494578 - Skipper GE, Fletcher C, Rocha-Judd R, Brase D. Tramadol Abuse and Dependence among Physicians. JAMA. 2004;292:1818-1819
- Skipper GE, Weinmann W, Wurst FM. Ethylglucuronide (EtG): A New Marker to Detect Alcohol Use in Recovering Physicians. Journal of Medical Licensure and Discipline, 2004,90(2), 14-17
http://www.ushealthtests.com/etg-testing-for-recovering-physicians.pdf - Skipper GE, Weinmann W, Theirauf A, Schaefer P, Wiesbeck G, Allen JP, Miller M, Wurst FM. Ethyl Glucuronide: A Biomarker to Identify Alcohol use by Health Professionals Recovering from Substance Use Disorders, Alcohol Alcohol. 2004 Sep-Oct;39(5):445-9. Epub 2004 Aug 2. Curriculum Vitae: Gregory E. Skipper, M.D. 10 of 21 pages
https://academic.oup.com/alcalc/article/39/5/445/203846
Wurst FM, Alexson S, Skipper GE, Wiesbeck G, Wolfersdorf M, Marques P, Metzger J, Gilg T, Weinmann W (2004) Fatty acid ethyl esters, ethyl glucuronide and methanol in the serum of alcoholics during detoxification. Alcohol Clin Exp Res 28:157A
https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/1156005 - Skipper GE, Schaefer P, Thierauf A, Weinmann W, Allen JP, Miller M, Wiesbeck GA, Wurst F M (2004) Detection of Surreptitious Alcohol Use Among Health Professionals Recovering from Substance-Related Disorders Using a New Marker, Ethyl Glucuronide. Addiction (submitted 12/03; #03/427)
https://www.sciencedirect.com/science/article/pii/S1044030503007657 - Wurst F M, Skipper GE, Weinmann W (2003) Ethyl glucuronide – the direct ethanol metabolite on the threshold from science to routine use. Addiction 98 (Suppl 2) 51-61
https://www.ncbi.nlm.nih.gov/pubmed/14984242 - Wurst F M., Vogel R., Jachau K., Varga A., Alling C., Skipper G.E., Alt A. (2003) Ethyl glucuronide detects recent alcohol use in forensic psychiatric inpatients. Alcohol Clin Exp Res 27: 471-476
https://www.ncbi.nlm.nih.gov/pubmed/12658113 - Journal highlight ACER 03/2003, Feature story: www.eurekalert.com. (American Association for the Advancement of Science)
https://etg.weebly.com/uploads/7/4/7/5/74751/etg_advisory.2005.09.pdfWe are committed to serving our community. That's why we offer a variety of outreach programs, including health fairs, free screenings, and educational events.
Dr. Goldenberg's Publications
Dr. Goldenberg's Research Papers (Peer Reviewed)
- Bell, Matthew C., Goldenberg, Matthew, McDevitt, Margaret A., The Influence of Intertrial Interval Food on Extinction and Devaluation in Chain Schedules, The Journal Of General Psychology, April, 2006. 134: 133-152.
https://www.ncbi.nlm.nih.gov/pubmed/17503691 - Rashi Agarwal, MD, Matthew Goldenberg, DO, Robert Perry, MD, and Waguih William Ishak, MD, FAPA. The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innovations in Clinical Neuroscience. 2012 May-Jun; 9(5-6): 10–21.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398685/ - Fakhry H, Goldenberg M, Sayer G, Aye SS, Bagot K, Pi S, Ghazzaoui R, Vo N, Gowrinathan S, Bolton M, IsHak WW. Health Related Quality of Life in Childhood Cancer. Journal of Developmental & Behavioral Pediatrics. 2013 July/August;34(6):419-440.
https://journals.lww.com/jrnldbp/Abstract/2013/07000/Health_Related_Quality_of_Life_in_Childhood_Cancer.7.aspx - Matthew Goldenberg. A Psychiatric Perspective on Tobacco Use Disorder and Smoking Cessation. American Journal of Psychiatry-Residents’ Journal. February, 2014; 9 (2): 2.
https://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/February_2014.pdf - Matt Goldenberg. Opioid Overdoses: A Guide to Stem the Tide. American Journal of Psychiatry-Residents’ Journal. September, 2014; 9 (9): 6.
https://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/Sept_2014.pdf - Matthew Goldenberg, I Danovitch, WW IsHak. Quality of Life and Smoking. The American Journal on Addictions. Volume 23, Issue 6, pages 540–562, November-December 2014
https://www.ncbi.nlm.nih.gov/pubmed/25255868 - Goldenberg M, Hassamal S, IsHak WW, Haglund M, Miotto K, Danovitch I. A Call to Action: The Active Role Psychiatrists and the DEA Must Take to Decrease Harm from Psychotropic Drugs Acquired via the Internet. J Clin Psychiatry. 2016 Nov;77(11)
https://www.ncbi.nlm.nih.gov/pubmed/28076677 - Danovitch I, Steiner AJ, Kazdan A, Goldenberg M, Haglund M, Mirocha J, Collison K, Vanle B, Dang J, IsHak WW. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders. J Addict Med. Jan/Feb 2017; 11 (1), 47-54.
https://www.ncbi.nlm.nih.gov/pubmed/27763941 - Hassmal S, Goldenberg M, IsHak WW, Haglund M, Miotto K, Danovitch I. Overcoming Barriers to Initiating Medication Assisted Treatment for Heroin Use Disorder in a General Medical Hospital: a case report and narrative literature review. Accepted to the Journal of Psychiatric Practice on March 17, 2016 [In Press].
https://www.ncbi.nlm.nih.gov/pubmed/28492461 - Goldenberg M, IsHak WW, Danovitch I. Quality of Life and Recreational Cannabis Use. The American Journal on Addictions. Jan 2017; 26 (1), 8-25.
https://www.ncbi.nlm.nih.gov/pubmed/28000973 - Goldenberg M, Reid MW, IsHak WW, Danovitch I. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug Alcohol Depend. 2017 Mar 1;174:80-90. [Epub ahead of print]. PubMed PMID:28319753.
https://www.ncbi.nlm.nih.gov/pubmed/28319753We are committed to serving our community. That's why we offer a variety of outreach programs, including health fairs, free screenings, and educational events.